- Home
- CZR vs KYMR Comparison
CZR vs KYMR Comparison
Compare CZR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- KYMR
- Stock Information
- Founded
- CZR 1937
- KYMR 2015
- Country
- CZR United States
- KYMR United States
- Employees
- CZR N/A
- KYMR N/A
- Industry
- CZR Hotels/Resorts
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- CZR Consumer Discretionary
- KYMR Health Care
- Exchange
- CZR Nasdaq
- KYMR Nasdaq
- Market Cap
- CZR 4.6B
- KYMR 4.3B
- IPO Year
- CZR 1989
- KYMR 2020
- Fundamental
- Price
- CZR $18.73
- KYMR $60.03
- Analyst Decision
- CZR Strong Buy
- KYMR Strong Buy
- Analyst Count
- CZR 14
- KYMR 18
- Target Price
- CZR $39.36
- KYMR $65.56
- AVG Volume (30 Days)
- CZR 8.4M
- KYMR 627.7K
- Earning Date
- CZR 10-28-2025
- KYMR 11-04-2025
- Dividend Yield
- CZR N/A
- KYMR N/A
- EPS Growth
- CZR N/A
- KYMR N/A
- EPS
- CZR N/A
- KYMR N/A
- Revenue
- CZR $11,369,000,000.00
- KYMR $44,711,000.00
- Revenue This Year
- CZR $3.49
- KYMR $60.88
- Revenue Next Year
- CZR $3.00
- KYMR N/A
- P/E Ratio
- CZR N/A
- KYMR N/A
- Revenue Growth
- CZR 0.87
- KYMR N/A
- 52 Week Low
- CZR $18.64
- KYMR $19.45
- 52 Week High
- CZR $45.65
- KYMR $63.96
- Technical
- Relative Strength Index (RSI)
- CZR 26.31
- KYMR 57.90
- Support Level
- CZR $21.44
- KYMR $55.26
- Resistance Level
- CZR $23.37
- KYMR $62.03
- Average True Range (ATR)
- CZR 0.95
- KYMR 2.93
- MACD
- CZR -0.17
- KYMR -0.28
- Stochastic Oscillator
- CZR 1.80
- KYMR 54.83
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.